David Westenberg
Stock Analyst at Piper Sandler
(4.70)
# 159
Out of 5,138 analysts
189
Total ratings
60.75%
Success rate
28.92%
Average return
Main Sectors:
Stocks Rated by David Westenberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEOG Neogen | Reiterates: Neutral | $6.5 → $10 | $9.46 | +5.71% | 14 | Jan 12, 2026 | |
| BLLN BillionToOne | Initiates: Overweight | $150 | $94.72 | +58.36% | 1 | Dec 1, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $15 → $19 | $21.20 | -10.38% | 3 | Nov 11, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $105 → $80 | $68.92 | +16.08% | 6 | Nov 11, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Neutral | $1.5 → $2 | $2.35 | -14.89% | 10 | Nov 11, 2025 | |
| NTRA Natera | Maintains: Overweight | $220 → $230 | $240.34 | -4.30% | 17 | Nov 11, 2025 | |
| FLGT Fulgent Genetics | Maintains: Neutral | $21 → $30 | $28.65 | +4.71% | 10 | Nov 11, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $70 → $80 | $102.34 | -21.83% | 13 | Nov 11, 2025 | |
| CTKB Cytek Biosciences | Maintains: Overweight | $8 → $7.5 | $5.62 | +33.45% | 10 | Nov 11, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $200 | $190.26 | +5.12% | 8 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $90 | $111.98 | -19.63% | 10 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $17.78 | +12.49% | 15 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $140 | $109.28 | +28.11% | 3 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $215 | $125.28 | +71.62% | 15 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $510 → $700 | $712.12 | -1.70% | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $18 | $24.18 | -25.56% | 10 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $11 | $12.83 | -14.26% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $185 | $145.30 | +27.32% | 16 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $260 → $280 | $268.89 | +4.13% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $35.38 | - | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $33.91 | - | 1 | Nov 21, 2017 |
Neogen
Jan 12, 2026
Reiterates: Neutral
Price Target: $6.5 → $10
Current: $9.46
Upside: +5.71%
BillionToOne
Dec 1, 2025
Initiates: Overweight
Price Target: $150
Current: $94.72
Upside: +58.36%
10x Genomics
Nov 11, 2025
Maintains: Neutral
Price Target: $15 → $19
Current: $21.20
Upside: -10.38%
Tempus AI
Nov 11, 2025
Maintains: Neutral
Price Target: $105 → $80
Current: $68.92
Upside: +16.08%
Pacific Biosciences of California
Nov 11, 2025
Maintains: Neutral
Price Target: $1.5 → $2
Current: $2.35
Upside: -14.89%
Natera
Nov 11, 2025
Maintains: Overweight
Price Target: $220 → $230
Current: $240.34
Upside: -4.30%
Fulgent Genetics
Nov 11, 2025
Maintains: Neutral
Price Target: $21 → $30
Current: $28.65
Upside: +4.71%
Exact Sciences
Nov 11, 2025
Maintains: Overweight
Price Target: $70 → $80
Current: $102.34
Upside: -21.83%
Cytek Biosciences
Nov 11, 2025
Maintains: Overweight
Price Target: $8 → $7.5
Current: $5.62
Upside: +33.45%
Quest Diagnostics
Oct 27, 2025
Maintains: Neutral
Price Target: $190 → $200
Current: $190.26
Upside: +5.12%
Oct 22, 2025
Maintains: Overweight
Price Target: $60 → $90
Current: $111.98
Upside: -19.63%
Oct 15, 2025
Maintains: Overweight
Price Target: $15 → $20
Current: $17.78
Upside: +12.49%
Sep 11, 2025
Maintains: Overweight
Price Target: $120 → $140
Current: $109.28
Upside: +28.11%
Aug 11, 2025
Maintains: Overweight
Price Target: $210 → $215
Current: $125.28
Upside: +71.62%
Aug 11, 2025
Maintains: Neutral
Price Target: $510 → $700
Current: $712.12
Upside: -1.70%
Aug 11, 2025
Maintains: Neutral
Price Target: $12 → $18
Current: $24.18
Upside: -25.56%
Aug 4, 2025
Maintains: Overweight
Price Target: $12 → $11
Current: $12.83
Upside: -14.26%
May 15, 2025
Maintains: Overweight
Price Target: $190 → $185
Current: $145.30
Upside: +27.32%
May 6, 2025
Maintains: Neutral
Price Target: $260 → $280
Current: $268.89
Upside: +4.13%
Jan 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $35.38
Upside: -
Nov 21, 2017
Initiates: Neutral
Price Target: n/a
Current: $33.91
Upside: -